Asacol Endaþarmsdreifa 10 mg/ml Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

asacol endaþarmsdreifa 10 mg/ml

tillotts pharma ab - mesalazinum inn - endaþarmsdreifa - 10 mg/ml

Asacol Magasýruþolin tafla 400 mg Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

asacol magasýruþolin tafla 400 mg

tillotts pharma ab - mesalazinum inn - magasýruþolin tafla - 400 mg

Asacol Magasýruþolin tafla 800 mg Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

asacol magasýruþolin tafla 800 mg

tillotts pharma ab - mesalazinum inn - magasýruþolin tafla - 800 mg

Asacol (Mesalazine ESPL) Tafla með breyttan losunarhraða 1600 mg Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

asacol (mesalazine espl) tafla með breyttan losunarhraða 1600 mg

tillotts pharma ab - mesalazinum inn - tafla með breyttan losunarhraða - 1600 mg

Metoject Stungulyf, lausn í áfylltri sprautu 50 mg/ml Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

metoject stungulyf, lausn í áfylltri sprautu 50 mg/ml

medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltri sprautu - 50 mg/ml

Spiolto Respimat Innöndunarlausn 2,5/2,5 míkróg Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

spiolto respimat innöndunarlausn 2,5/2,5 míkróg

boehringer ingelheim international gmbh* - tiotropii bromidum inn; olodaterolum hýdróklóríð - innöndunarlausn - 2,5/2,5 míkróg

Fintepla Euroopan unioni - islanti - EMA (European Medicines Agency)

fintepla

ucb pharma s.a.   - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptics, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.

Mycapssa Euroopan unioni - islanti - EMA (European Medicines Agency)

mycapssa

amryt pharmaceuticals dac - octreotide acetate - acromegaly - hinsveiflur og heilahimnubólur og hliðstæður - mycapssa is indicated for maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogues.

Metojectpen (Metoject) Stungulyf, lausn í áfylltum lyfjapenna 7,5 mg Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 7,5 mg

medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 7,5 mg

Metojectpen (Metoject) Stungulyf, lausn í áfylltum lyfjapenna 20 mg Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 20 mg

medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 20 mg